Tang Weihong, Yao Lu, Hoogeveen Ron C, Alonso Alvaro, Couper David J, Lutsey Pamela L, Steenson Carol C, Guan Weihua, Hunter David W, Lederle Frank A, Folsom Aaron R
1 Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
2 Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Angiology. 2019 Feb;70(2):130-140. doi: 10.1177/0003319718785278. Epub 2018 Jun 26.
Animal and human laboratory studies suggest that the pathogenesis of abdominal aortic aneurysms (AAAs) involves inflammation and degradation and remodeling of the extracellular matrix. This study prospectively assessed the association between biomarkers for these mechanisms and the presence of AAA during 24 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) study. The ARIC prospectively identified clinically diagnosed AAAs in 15 792 men and women from baseline in 1987 to 1989 to 2011 using hospital discharge codes and death records. Additional asymptomatic AAAs were detected by an abdominal ultrasound scan in 2011 to 2013. Matrix metalloproteinase (MMP)-3, MMP-9, interleukin 6 (IL-6), N-terminal propeptide of Type III procollagen (PIIINP), and osteopontin were measured in blood samples collected between 1987 and 1992 in participants with AAA (544 clinically diagnosed AAAs and 72 ultrasound-detected AAAs) and a random sample of 723 participants selected from baseline and matched with AAAs by age, race and sex. Higher concentrations of MMP-9 and IL-6 were associated with future risk of clinically diagnosed AAA (hazard ratios [95% confidence intervals]: 1.55 [1.22-1.97] and 1.87 [1.48-2.35], respectively, comparing highest versus lowest tertiles) after multivariable adjustment ( P for trend < .001). Matrix metalloproteinase-9 was also associated with ultrasound-detected AAA. In conclusion, blood concentrations of MMP-9 and IL-6 measured in middle age predicted the risk of AAA during 24 years of follow-up.
动物和人体实验室研究表明,腹主动脉瘤(AAA)的发病机制涉及炎症以及细胞外基质的降解和重塑。本研究在社区动脉粥样硬化风险(ARIC)研究中,对这些机制的生物标志物与随访24年期间AAA的存在之间的关联进行了前瞻性评估。ARIC研究前瞻性地利用医院出院编码和死亡记录,在1987年至1989年基线期到2011年期间,从15792名男性和女性中识别出临床诊断的AAA。2011年至2013年通过腹部超声扫描检测出更多无症状AAA。在1987年至1992年期间收集的血液样本中,对AAA患者(544例临床诊断的AAA和72例超声检测出的AAA)以及从基线期选取的723名按年龄、种族和性别与AAA匹配的随机样本参与者,检测了基质金属蛋白酶(MMP)-3、MMP-9、白细胞介素6(IL-6)、III型前胶原N端前肽(PIIINP)和骨桥蛋白。多变量调整后,较高浓度的MMP-9和IL-6与未来临床诊断AAA的风险相关(风险比[95%置信区间]:分别为1.55[1.22 - 1.97]和1.87[1.48 - 2.35],最高三分位数与最低三分位数相比)(趋势P <.001)。MMP-9也与超声检测出的AAA相关。总之,中年时测量的血液中MMP-9和IL-6浓度可预测24年随访期间AAA的风险。